STXS

Stereotaxis Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 2/10
  • Momentum 3/10
Stereotaxis sales and earnings growth
STXS Growth
Fair
  • Revenue Y/Y 19.61%
  • EPS Y/Y -3.70%
  • FCF Y/Y 30.73%
Stereotaxis gross and profit margin trends
STXS Profitability
Fair
  • Gross margin 53.10%
  • EPS margin -82.80%
  • ROIC -298.10%
Stereotaxis net debt vs free cash flow
STXS Risk
Great
  • Debt / Equity 0.5
  • Debt / FCF 0.0
  • Interest coverage NA

Stereotaxis stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗